Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide

Antiviral agents are urgently needed to fight severe acute respiratory syndrome (SARS). We showed that niclosamide, an existing antihelminthic drug, was able to inhibit replication of a newly discovered coronavirus, SARS-CoV; viral antigen synthesis was totally abolished at a niclosamide concentrati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wu, Chang-Jer, Jan, Jia-Tsrong, Chen, Chi-Min, Hsieh, Hsing-Pang, Hwang, Der-Ren, Liu, Hwan-Wun, Liu, Chiu-Yi, Huang, Hui-Wen, Chen, Su-Chin, Hong, Cheng-Fong, Lin, Ren-Kuo, Chao, Yu-Sheng, Hsu, John T. A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2004
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC434198/
https://ncbi.nlm.nih.gov/pubmed/15215127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.7.2693-2696.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados